Brief: Qlife's Core Patent Granted In Europe
Feb 23 (Reuters) - Qlife Holding AB QLIFE.ST :
* QLIFE'S CORE PATENT GRANTED IN EUROPE
* CORE PATENT FOR EGOO SYSTEM HAS BEEN GRANTED IN EU AND
OTHER
COUNTRIES IN EUROPEAN MARKET, AS WELL AS IN UNITED KINGDOM
Source text for Eikon: ID:nWkr3l8v5v
Further company coverage: QLIFE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Qlife Holding AB
See all newsAdvisory: Alerts on Qlife's agreement with global pharma company withdrawn
Brief: Qlife Holding Enters Feasibility Deal With Pharma Co For Egoo Health Biomarker
Brief: Qlife Holding Q1 EBITDA Loss SEK 5.5 Mln
Sweden's Qlife Q1 revenue drops, losses widen slightly
Brief: Qlife Holding Q4 EBITDA At SEK -1.6 Million